Albendazole Micro Labs 400mg chewable tablets (Micro Labs, Germany)
Section 19A approved medicine
Albendazole Micro Labs 400mg chewable tablets (Micro Labs, Germany)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Current
Medicines in short supply/unavailable
ESKAZOLE albendazole 400mg chewable tablet bottle - ARTG 97505
Indication(s)
Hydatid Disease:
The long-term use of albendazole is indicated for the treatment of hydatid cysts caused by E. granulosus in adults and adolescents with a body weight of ≥ 60 kg, where surgical intervention is not feasible because of anatomic site or the presence of multiple cysts. Albendazole shows greatest efficacy in the treatment of liver, lung and peritoneal cysts. Experience with bone cysts or those in the heart or central nervous system is limited, but cases of successful treatment with a prolonged course of albendazole have been reported.
Albendazole may also be used as an adjunct to surgical excision of hydatid cysts either:
- prior to surgical intervention, or
- post-operatively, if pre-operative treatment was too short (less than two separate 28 day cycles) or if viable cysts are found at surgery.
Images
